주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-03-29 13:21 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
Policy
목록
(
총 :
642 )
기사목록 보기 형태
제목형
요약형
포토형
K-Bio Vaccine Funds 1 & 2 raised ₩261.6 billion investment
Kwak Sung-sun
2023.11.08 15:35
Growing competition among dermatology clinics drives aggressive patient attraction tactics
Lee Han-soo
2023.11.07 10:01
Korea to expand mental health projects to lower suicide rate
Kim Eun-young
2023.11.06 15:18
KHIDI hosts Medical Korea 2023 in UAE to boost AI healthcare business
Kim Jung-chul
2023.11.06 14:04
Korea's largest poultry company faces backlash after chairman downplays recent bug incident
Lee Han-soo
2023.11.03 16:38
Korea’s animal-alternative skin irritation test recognized as ISO standard
Kim Chan-hyuk
2023.11.03 15:01
Korea to spend $3.6 million to help Africa CDC deal with infectious diseases
Kim Jung-chul
2023.11.03 11:43
[Special] When will young diabetics attain their long-cherished desire?
Park Gi-taek
2023.11.02 15:21
Enrollment quota for nursing school to increase by 1,000 from 2025
Kwak Sung-sun/Kim Ju-youn
2023.11.01 16:07
Only 16% of international students are satisfied with Korean health insurance: survey
Kim Ju-yeon
2023.11.01 15:32
2 new JAK inhibitors, Jyseleca and Jakavi, get insurance benefits this month
Kim Yun-mi
2023.11.01 11:32
Korea becomes 1 of 3 nations included in the initial WHO's WLA listing
Lee Han-soo
2023.11.01 10:10
처음
이전
이전
이전
11
12
13
14
15
16
17
18
19
20
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기